Evidence map›Paper›PMID 24837506›Full record

ArticleVaccine2014

IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection.

Lydia M Roberts, John S Davies, Gregory D Sempowski, Jeffrey A Frelinger

Abstract read
In one paragraph

Article in Vaccine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. The immune response toFrontiers in microbiology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Deletion Mutants ofPathogens (Basel, Switzerland) · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Adaptive Immunity toFrontiers in cellular and infection microbiology · 2018
    Review
  14. Article
  15. DifferentialFrontiers in immunology · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lydia M RobertsDepartment of Immunobiology, University of Arizona, 1656 E. Mabel Street, MRB 218,Tucson, AZ 85718, United States.
John S DaviesDepartment of Immunobiology, University of Arizona, 1656 E. Mabel Street, MRB 218,Tucson, AZ 85718, United States.
Gregory D SempowskiDuke Human Vaccine Institute, 909 S. LaSalle Street, Durham, NC 27710, United States.
Jeffrey A FrelingerDepartment of Immunobiology, University of Arizona, 1656 E. Mabel Street, MRB 218,Tucson, AZ 85718, United States. Electronic address: jfrelin@email.arizona.edu.

Funding

Yessinia autotransporters (Yaps): Structure, function, and host responseU54AI057157 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GOLDMAN, WILLIAM E · 2003 to 2013
$91.4M
Regional Biocontainment Laboratory (RBL)UC6AI058607 · NIAID · DUKE UNIVERSITY · PI WILLIAMS, R SANDERS · 2003 to 2005
$16.3M
Immune Evasion by F. tularensisR01AI078345 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FRELINGER, JEFFREY ALLEN · 2009 to 2013
$1.8M
NIAID NIH HHS R01 AI078345NIAID NIH HHS U54 AI057157NIAID NIH HHS UC6 AI058607
6 · The paper itself

Abstract

IL-17 and IFN-γ production by Th17 and Th1 cells, respectively, is critical for survival during primary respiratory infection with the pathogenic bacterium, Francisella tularensis Live Vaccine Strain (LVS). The importance, however, of these T cell subsets and their soluble mediators is not well understood during a secondary or memory response. We measured the number of CD4(+) T cells producing IFN-γ or IL-17 in the spleen and lungs of vaccinated mice on day four of the secondary response using intracellular cytokine staining in order to identify protective T cell subsets participating in the memory response. Few bacteria were present in spleens of vaccinated mice on day four and a T cell response was not observed. In the lung, where more bacteria were present, there was a robust Th1 response in vaccinated mice but Th17 cells were not present at higher numbers in vaccinated mice compared to unvaccinated mice. These data show that the lung is the dominant site of the secondary immune response and suggest that Th17 cells are not required for survival during secondary challenge. To further investigate the importance of IFN-γ and IL-17 during the secondary response to F. tularensis, we neutralized either IFN-γ or IL-17 in vivo using monoclonal antibody treatment. Vaccinated mice treated with anti-IFN-γ lost more weight and had higher bacterial burdens compared to vaccinated mice treated with isotype control antibody. In contrast, treatment with anti-IL-17A antibody did not alter weight loss profiles or bacterial burdens compared to mice treated with isotype control antibody. Together, these results suggested that IFN-γ is required during both primary and secondary respiratory F. tularensis infection. IL-17, on the other hand, is only critical during the primary response to respiratory F. tularensis but dispensable during the secondary response.

Indexed as

Immunity, CellularAnimalsAntibodies, BacterialAntibodies, MonoclonalBacterial LoadBacterial VaccinesFemaleFrancisella tularensisImmunoglobulin GImmunologic MemoryInterferon-gammaInterleukin-17LungMice, Inbred C57BLSpleenT-Lymphocyte SubsetsAntibodies, BacterialAntibodies, MonoclonalBacterial VaccinesImmunoglobulin GInterferon-gammaInterleukin-17Vaccines, AttenuatedclpBFrancisella tularensisIL-17Interferon-gammaIntranasalSecondary response

Identifiers

PMID24837506
PMCPMC4075325

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.